First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a phase 1 study in healthy subjects to evaluate the safety, tolerability and pharmacokinetics of single (Part A and B) and multiple (Part B) doses of inhaled TD-0903.
Epistemonikos ID: 19e44d82a0086ab8087a65e3859465f90a50e915
First added on: Apr 18, 2020